Archive for 2009/01


Join Us For The Premier Allergy/immunology Meeting In 2009

The world's leading researchers in allergic disease will meet in Washington, DC, March 13-17, 2009, for the American Academy of Allergy, Asthma & Immunology's (AAAAI) 2009 Annual Meeting. The AAAAI Annual Meeting is the largest U.S. gathering of allergist/immunologists, allied health professionals and researchers from around the world.
(more...)


01/30/2009 | Respiratory & Asthma - Allergy | Trackback | Comments Off

‘Rescue Course’ Of Antenatal Steroids Improves Outcome In Premature Babies

In a study presented at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, researchers unveiled findings that show that premature babies born before 34 weeks have a 31 percent reduction in serious complications when given a "rescue course" of Antenatal Corticosteroids (ACS) steroids with no adverse side effects noted. "Premature babies are very susceptible to respiratory problems which may lead to additional severe complications," said Dr. James Kurtzman, M.D.
(more...)


01/29/2009 | Respiratory & Asthma - Pediatrics / Children's Health | Trackback | Comments Off

Kaiser Permanente Bellflower Medical Center January 28, 2009 Evening Update - All Are Doing Well!

Kaiser Permanente announced yesterday evening that mom and the octuplets continue to do well. Kaiser Permanente's Bellflower Medical Center also reports that five of the babies are now breathing room air, while three are getting oxygen through a tube in their nose. It is anticipated that soon all babies will be off assisted oxygen. Of the eight babies, four currently are being tube-fed donated breast milk, one less than earlier reported.
(more...)


01/29/2009 | Respiratory & Asthma - Respiratory / Asthma | Trackback | Comments Off

Healthy Indoor Environments Protect Children’s Health

The financial crisis could lead to greater use of cheap heating fuels and burning of waste at home, increasing risks to children's health. This adds urgency to discussions taking place in preparation for the Fifth Ministerial Conference on Environment and Health in 2010.
(more...)


01/29/2009 | Respiratory & Asthma - Respiratory / Asthma | Trackback | Comments Off

Clearing The Dust: Asthma Program Educates Community

Using a Florida elementary school as a testing site, researchers have found that a targeted asthma education program effectively increased understanding and dispelled some prevalent myths about this common childhood disease. In the
(more...)


01/29/2009 | Respiratory & Asthma - Respiratory / Asthma | Trackback | Comments Off

Record Attendees, Presentations And Exhibitors At Drug Delivery To The Lungs 19

Last month saw the meeting of one of Europe's premier respiratory drug delivery conferences, DDL19. Held at the Edinburgh International Conference Centre, DDL19 brought together over 420 of the world's leading authorities in the field; the highest number of attendees in the conference's nineteen year history; to meet, present and discuss the latest advances in pulmonary drug delivery.
(more...)


01/29/2009 | Respiratory & Asthma - Respiratory / Asthma | Trackback | Comments Off

Oxygen Biotherapeutics, Inc. Submits Request For Designation To FDA For Oxycyte(R)-based Wound Care Product

Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) announced that the company has submitted a preliminary Request For Designation (RFD) to the FDA for its first wound care product. The RFD submission is part of a process with the FDA for determining which agency component will have primary jurisdiction for a drug, device or biological product. The product is Oxycyte® Gel in a single-dose packaging delivered as an ointment onto wounds and is protected by a standard bandage.
(more...)


01/29/2009 | Respiratory & Asthma - Respiratory / Asthma | Trackback | Comments Off

FDA Warns Consumers Against Dietary Supplement Containing Undeclared Drug

The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine. Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug that poses potential safety risks. "Sibutramine is the active ingredient in an FDA-approved prescription drug used as an appetite suppressant for weight loss," said Janet Woodcock, M.D.
(more...)


01/28/2009 | Complememntary & Alternative Medicine - Complementary Medicine / Alternative Medicine | Trackback | Comments Off

Pain Relieving Effects Of Acupuncture Are Limited

The pain relieving effects of acupuncture compared with placebo are small and seem to lack clinical relevance, according to a study published on bmj.com today. Researchers at the Nordic Cochrane Centre in Copenhagen analysed evidence from thirteen acupuncture pain trials involving over 3,000 patients.
(more...)


01/28/2009 | Complememntary & Alternative Medicine - Pain / Anesthetics | Trackback | Comments Off

FDA Warns Consumers Against Dietary Supplement Containing Undeclared Drug

The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine. Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug that poses potential safety risks. “Sibutramine is the active ingredient in an FDA-approved prescription drug used as an appetite suppressant for weight loss,” said Janet Woodcock, M.D.


(more...)


01/28/2009 | Complememntary & Alternative Medicine - Complementary Medicine / Alternative Medicine | Trackback | Comments Off

« Previous Entries

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

- -

>-- Top of Page --<